Do you have the right strategy for cell line and clone development success?

Doing things quickly has become a paradigm in biopharma development. Simultaneously, in early development, variability is required to extract the most data and increase chances of success. This leads to a demand in high-throughput, automated techniques, and highly skilled professionals. Risk taking and early adoption of new techniques is part of innovation to optimize workflows, especially when projects are highly individual and cannot follow standard routines. In clone development, this includes working with very different host cell lines, customized protocols, and unforeseen circumstances which needs adaptable processes and multifunctional devices.

In this webinar, Dr. Vicky Goralczyk and Dr. Lena Thoring, Directors of Cell Line Development and Bioprocess Development at FyoniBio GmbH, will present data on how the CellCelector system can effectively be used for cell line development, host cell engineering, and cell adaptation. They will also cover how it was successfully integrated into FyoniBio‘s platform for the development of biopharmaceutics for autologous and allogeneic cell therapies.

Key learning objectives

• Learn how to identify key development and manufacturing challenges.
• Gain insight into commercial scalability strategies for late-stage cell therapies.
• Discover ways to innovate and accelerate the delivery of cell therapies to patients.
• Learn how, when, and why you should leverage state-of-the-art technologies.
• Explore the importance of end-to-end supply chain management.

Who should attend?

• Researchers looking for monoclonality assurance and comprehensive documentation.
• Organizations looking to significantly decrease their overall cell line development workflow duration.

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.